ОБЗОР2018
Tsyganov M.M., Deryusheva I.V., Rodionov E.O., Ibragimova M.K., Miller S.V., Litviakov N.V.
Surgery results of the treatment of the stage II–III lung cancer remains to be unsatisfactory, and used the chemotherapy fails to improve the survival. The main obstacle is the use of standard clinical parameters for the treatment strategy and not enough effec…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Paltseva E.M., Varlamov A.V., Sekacheva M.I., Fedorov D.N., Skipenko O.G.
Introduction. The elevated expression of components of DNA repair system ERCC1 (excision repair cross-complementing group 1) and XPD (Xeroderma pigmentosum group D) is associated with the lack of efficacy of DNA–damaging cytotoxic platinum-based preparations. …